Dalhousie University reserving 40 nursing seats for Indigenous, Black students cbc.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cbc.ca Daily Mail and Mail on Sunday newspapers.
Article content
A team of lawyers for Meng Wanzhou, 49, will seek to convince a Vancouver judge in hearings that begin Wednesday that the U.S. request to extradite her from Canada is deeply flawed, that her rights were abused, and that she should be released. If history is any guide, that argument will be tough of the 798 U.S. handover requests received since 2008, Canada has only refused or discharged eight, according to Canada’s Department of Justice. Forty cases were withdrawn by the U.S.
We apologize, but this video has failed to load.
Try refreshing your browser, or Huawei s Meng Wanzhou enters final extradition hearings facing steep odds Back to video
Biotech firms are typically the long-haulers of the entrepreneurial set, and Tetra Bio-Pharma is no exception.
For years, scientists at the Orléans-based company have been patiently toiling away on a drug that provides the anti-inflammatory benefits of CBD, a therapeutic ingredient found in cannabis, but without some of the side effects that can include nausea, headaches and fatigue.
After millions of dollars’ worth of research and tens of thousands of hours of painstaking effort, Tetra founder Guy Chamberland and his team say the product is on the cusp of finally being ready for market – and not a moment too soon.
Governments only buy and distribute vaccines after studying them to make sure they work and are safe. Researcher Alyson Kelvin, pictured here at the University of Saskatchewan’s Vaccine and Infectious Disease Organization, has spent the past 20 years preparing vaccines that could be used to tackle viruses like the coronavirus. (Image credit: Liam Richards/The Canadian Press) 2/ Do the COVID-19 vaccines work? More than 43,000 people were involved in the testing process for the Pfizer-BioNTech vaccine, which is the first COVID-19 vaccine to be approved in Canada. That’s one of the largest groups to ever be involved in testing a vaccine like this.